Title
Category
Credits
Event date
Cost
Review of Risk Factors in the Identification of Primary Open Angle Glaucoma
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will examine risk factors for glaucoma that will assist health care professionals (HCPs) in the early identification of this condition in general primary eye care practice. Individual risk factors will be discussed, and pertinent literature will be reviewed to provide insight into how certain factors in combination, such as Krukenberg spindles, homogeneous trabecular meshwork pigmentation and iris transillumination defects can indicate an increased risk and alert HCPs to the presence of this disorder. A new tool will be introduced to help recommend when specific glaucoma testing is indicated.
Health Disparities in Obesity
  • Health equity
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
$0.00
This activity will review the prevalence of obesity in different populations and its role in the development of chronic disease. It will discuss the effects of bias, discrimination, and health disparities on the development and treatment of obesity. Importantly, it will educate participants about the benefits of a multi-modal collaborative treatment approach to mitigate contributing factors to obesity and address challenges in access to care that can influence obesity-related health outcomes in certain communities.
Integrating Care Teams in a Virtual World
  • Digital health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will examine how the multiple aspects of digital health can be best utilized by health care team members to ensure continuity of the patient’s health care journey, meet care plan goals, improve patient outcomes and optimize team communication practices. The ability of virtual health care practices to enable team members to fulfill their roles in clinical decision-making and care plan implementation will be discussed. Important legal, regulatory and reimbursement considerations that pertain to digital practice integration within the health care team will be highlighted.
Systemic Mastocytosis: Diagnostic and Therapeutic Updates
  • Disease management
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
$0.00
This activity will review the symptoms and signs of SM, provide an overview of new and current therapies and identify SM guideline updates. The value of an interdisciplinary team–based approach along the continuum of care for affected individuals will also be discussed as a definitive step toward optimizing outcomes. 
Treatment Options for Ocular Anterior Surface Disease
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Ocular Anterior Surface Disease or dry eye syndrome affects nearly 16 million Americans and can be a common and chronic problem for adults, especially for those of advanced age, causing symptoms that interfere with eye comfort, function and quality of life. Competent evaluation to determine the etiology of dry eye syndrome is necessary for successful symptom management as therapeutic regimens must be specific to the underlying causes to be effective. This activity will examine the multiple parts of eye anatomy, the dysfunction of which may contribute to dry eye syndrome, including the tear film, ocular anterior surface and Meibomian gland, and identify complications that can result when dry eye is left untreated. Importantly, a thorough review of optimal treatment regimens will be provided, as well as updates on newer and emerging targeted treatments, with a focus on providing relief and preventing further damage to the eye.
Advanced Degenerative Joint Disease and Chronic Lower Back Pain: Evidence-Based Approaches to Care
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will provide participants with insight into newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses.
The Diagnostic Odyssey for Individuals With Rare Diseases: Pompe Disease and Other Lysosomal Storage Diseases
  • Disease management
  • Health equity
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.
The Diagnostic Odyssey for Individuals With Rare Diseases: Spotlight on the Patient, Pompe Disease (Podcast)
  • Disease management
  • Health equity
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 ASWB - Social Workers
$0.00
In this podcast Nealie White, an individual with Pomp disease, will share her insights and perspectives, and panelists will provide strategies that the interprofessional health care team can utilize to better support people who are impacted by rare diseases.
Monkeypox Explained: Symptoms, Transmissibility and Prevention
  • Infectious diseases
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 APA - Psychologists
  • 0.50 Attendance - General Attendance
  • 0.50 ASWB - Social Workers
$0.00
This activity will provide participants with the latest science on monkeypox, describing the spectrum of associated symptoms and signs, virulence, and common routes of transmission. Discussion will also focus on the factors driving this outbreak, approaches to prevention and management, and an overview of the impact of this disease globally and in comparison with the current COVID-19 public health emergency.
Monkeypox Explained: Causes, Incidence, Pain/Symptom Management, At Risk Populations and Outcomes
  • Infectious diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 ASWB - Social Workers
$0.00
This activity will provide participants with the latest information on the status of the MP outbreak, including its origin, at-risk populations, efficacy of available vaccines, pain and symptom management, risks of delayed diagnosis and mortality. Emerging research on MP prevention and treatment interventions will also be discussed.

Pages